Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model

Journal of Infectious Diseases

Volumn 174, Issue 6, 1996, Pages 1337-1340

  Kauppi Korkeila, Maija ^b   Van Alphen, Lock ^b   Madore, Dace ^b   Saarinen, Leena ^b   Käyhty, Helena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN FC FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM ADHERENCE; HAEMOPHILUS INFLUENZAE TYPE B; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MUCOSA; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029828248     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.6.1337     Document Type: Article

References (15)

1. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
2. Eskola J, Takala AK, Käyhty H, Koskenniemi E, Peltola H, Mäkelä PH. Protection achieved by Haemophilus influenzae type b (Hib) conjugate vaccines is better than expected on the basis of efficacy trials [abstract 979]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992:273.
3. Kauppi M, Saarinen L, Käyhty H. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J Infect Dis 1993;167:365-71.
4. Kauppi M, Eskola J, Käyhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 1995;14:286-94.
5. Van Alphen L, Eijk P, Käyhty H, van Marle J, Dankert J. Antibodies to PRP affect adherence and multiplication of Haemophilus influenzae type b. Infect Immun 1996;64:995-1001.
6. Van Alphen L, Riemens J, Poolman J, Hopman C, Zanen HC. Homogeneity of cell envelope protein subtypes, lipopolysaccharide serotypes and biotypes among Haemophilus influenzae type b from patients with meningitis in the Netherlands. J Infect Dis 1983;148:75-80.
7. Noel GJ, Mosser DM, Edelson PJ. Role of complement in mouse macrophage binding of Haemophilus influenzae. J Clin Invest 1990;85:208-18.
8. Johnstone A, Thorpe R. Immunochemistry in practice. 2nd ed. Boston: Blackwell Scientific Publications, 1987:61-4.
9. Hudson L, Hay FC. Practical immunology. 2nd ed. Boston: Blackwell Scientific Publications, 1980:142-5.
10. Ma JKC, Hunjan M, Smith R, Kelly C, Lehner T. An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutons. Infect Immun 1990;58:3407-14.
11. Steele EJ, Chaicumba W, Rowley D. Further evidence for cross-linking as a protective factor in experimental cholera: properties of antibody fragments. J Infect Dis 1975;132:175-80.
12. Bell DY, Haseman YA, Spock A, McLennan G, Hook GER. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Am Rev Respir Dis 1981;124:72-9.
13. van de Graaf EA, Jansen HM, Bakker MM, Alberts C, Eeftinck Schattenkerk JK, Out TA. ELISA of complement C3a in bronchoalveolar lavage fluid. J Immunol Methods 1992;147:241-50.
14. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979;97:149-99.
15. Reynolds HY, Kazmierowski JA, Newball HH. Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest 1975;56:376-85.